Genetic variation in LIN28B is associated with the timing of puberty
- PMID: 19448623
- PMCID: PMC3000552
- DOI: 10.1038/ng.382
Genetic variation in LIN28B is associated with the timing of puberty
Abstract
The timing of puberty is highly variable. We carried out a genome-wide association study for age at menarche in 4,714 women and report an association in LIN28B on chromosome 6 (rs314276, minor allele frequency (MAF) = 0.33, P = 1.5 × 10(-8)). In independent replication studies in 16,373 women, each major allele was associated with 0.12 years earlier menarche (95% CI = 0.08-0.16; P = 2.8 × 10(-10); combined P = 3.6 × 10(-16)). This allele was also associated with earlier breast development in girls (P = 0.001; N = 4,271); earlier voice breaking (P = 0.006, N = 1,026) and more advanced pubic hair development in boys (P = 0.01; N = 4,588); a faster tempo of height growth in girls (P = 0.00008; N = 4,271) and boys (P = 0.03; N = 4,588); and shorter adult height in women (P = 3.6 × 10(-7); N = 17,274) and men (P = 0.006; N = 9,840) in keeping with earlier growth cessation. These studies identify variation in LIN28B, a potent and specific regulator of microRNA processing, as the first genetic determinant regulating the timing of human pubertal growth and development.
Figures
Comment in
-
Genetics of reproductive lifespan.Nat Genet. 2009 Jun;41(6):637-8. doi: 10.1038/ng0609-637. Nat Genet. 2009. PMID: 19471299 No abstract available.
References
-
- Parent AS, et al. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr. Rev. 2003;24:668–693. - PubMed
-
- Lakshman R, et al. Association between age at menarche and risk of diabetes in adults: results from the EPIC-Norfolk cohort study. Diabetologia. 2008;51:781–786. - PubMed
-
- Gajdos ZK, Hirschhorn JN, Palmert MR. What controls the timing of puberty? An update on progress from genetic investigation. Curr. Opin. Endocrinol. Diabetes Obes. 2009;16:16–24. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- G0401527(74922)/MRC_/Medical Research Council/United Kingdom
- 068545/Z/02/WT_/Wellcome Trust/United Kingdom
- G0701863/MRC_/Medical Research Council/United Kingdom
- MC_U105630924/MRC_/Medical Research Council/United Kingdom
- 077016/WT_/Wellcome Trust/United Kingdom
- MC_U106179471/MRC_/Medical Research Council/United Kingdom
- 076467/Z/05/Z/WT_/Wellcome Trust/United Kingdom
- G0401527/MRC_/Medical Research Council/United Kingdom
- G0600717/MRC_/Medical Research Council/United Kingdom
- 068049/WT_/Wellcome Trust/United Kingdom
- MC_U106188470/MRC_/Medical Research Council/United Kingdom
- CRUK_/Cancer Research UK/United Kingdom
- G9815508/MRC_/Medical Research Council/United Kingdom
- MC_U123092721/MRC_/Medical Research Council/United Kingdom
- U.1061.00.001 (79471)/MRC_/Medical Research Council/United Kingdom
- 077011/WT_/Wellcome Trust/United Kingdom
- MC_U106179473/MRC_/Medical Research Council/United Kingdom
- MC_U123092720/MRC_/Medical Research Council/United Kingdom
- MC_U106179472/MRC_/Medical Research Council/United Kingdom
- 73437/MRC_/Medical Research Council/United Kingdom
- 079996/WT_/Wellcome Trust/United Kingdom
- 077016/Z/05/Z/WT_/Wellcome Trust/United Kingdom
- G0000934/MRC_/Medical Research Council/United Kingdom
- U.1061.00.004(79472)/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
